oxaliplatin Injectable Solution

Brand(s)
Eloxatin
Category(s)
prescription
SPL Type(s)
Human Prescription, Human Prescription with Highlights
Master SPL
Sanofi-Aventis U.S. Llc (2015-10-08)
Oldest Current Product
2006-06-02
License(s)
NDA, NDA AUTHORIZED GENERIC, ANDA
RxNORM
INJECTABLE SOLUTION\OXALIPLATIN
FDAOB
IV (INFUSION)\INJECTION\OXALIPLATIN\rdfq
SPL Active
INTRAVENOUS\INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION\OXALIPLATIN
INTRAVENOUS\INJECTION, SOLUTION, CONCENTRATE\OXALIPLATIN
INTRAVENOUS\INJECTION, SOLUTION\OXALIPLATIN
INTRAVENOUS\POWDER, FOR SOLUTION\OXALIPLATIN
SPL Moiety
INTRAVENOUS\INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION\OXALIPLATIN
INTRAVENOUS\INJECTION, SOLUTION, CONCENTRATE\OXALIPLATIN
INTRAVENOUS\INJECTION, SOLUTION\OXALIPLATIN
INTRAVENOUS\POWDER, FOR SOLUTION\OXALIPLATIN

product(s) by strength(s)

oxaliplatin 5 mg/ml injectable solution

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000240591EloxatinNDASanofi-Aventis U.S. Llc2006-06-02OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATENDA0217593c740b43-f396-4998-bc66-6964a21f7161
2007033986NDATeva Parenteral Medicines, Inc2009-08-11OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATENDA0221609e51cc79-620c-48d7-b267-78e43c1ef6e4
3125160592EloxatinNDAAventis Pharma Ltd.2009-07-22OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATENDA02175998e269f3-fd0f-4415-bf73-0cf6a1907204
4633230212NDAApp Pharmaceuticals, Llc2014-09-08OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATENDA0221600fabb87d-72ff-4325-86dc-b53da680361e

generic product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000690067ANDAPfizer Labs2012-08-09OXALIPLATININTRAVENOUSPOWDER, FOR SOLUTIONANDA200979e0890b0c-c1e9-4760-8914-0f28467d0e36
2000690070ANDAPfizer Labs2012-08-09OXALIPLATININTRAVENOUSINJECTION, SOLUTIONANDA091358b114b6c1-8a19-480c-8459-c23cbdc3516a
3007813315ANDASandoz Inc2015-03-01OXALIPLATININTRAVENOUSINJECTION, SOLUTIONANDA078817ab162009-6f84-4d56-ab56-5e84409ec814
4007813317ANDASandoz Inc2015-03-01OXALIPLATININTRAVENOUSINJECTION, SOLUTIONANDA078817ab162009-6f84-4d56-ab56-5e84409ec814
5009551725NDA AUTHORIZED GENERICWinthrop U.S.2014-07-07OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATENDA021759a98b4070-822f-4fba-a844-690ff5556f0b
6009551727NDA AUTHORIZED GENERICWinthrop U.S.2014-07-07OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATENDA021759a98b4070-822f-4fba-a844-690ff5556f0b
7009551731NDA AUTHORIZED GENERICWinthrop U.S.2015-09-01OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATENDA02175970269278-fe61-4800-a064-32cb6845cc28
8009551733NDA AUTHORIZED GENERICWinthrop U.S.2015-09-01OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATENDA02175970269278-fe61-4800-a064-32cb6845cc28
9250210211ANDASagent Pharmaceuticals2012-08-09OXALIPLATININTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA0788036d020a9b-1244-45e5-b8d7-8342e85d7666
10250210212ANDASagent Pharmaceuticals2012-08-09OXALIPLATININTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA0788036d020a9b-1244-45e5-b8d7-8342e85d7666
11250210233ANDASagent Pharmaceuticals2014-09-15OXALIPLATININTRAVENOUSINJECTION, SOLUTIONANDA20386929a5d098-bfa7-4a65-bb4f-5daa1fef1c2f
12416160176ANDASun Pharma Global Inc.2009-08-19OXALIPLATININTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA078818a83ff94d-956e-48de-bcb2-affff1c6f161
13416160178ANDASun Pharma Global Inc.2009-08-19OXALIPLATININTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA078818a83ff94d-956e-48de-bcb2-affff1c6f161
14459630611ANDAActavis Inc.2015-01-05OXALIPLATININTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA07880378f6a5f3-d088-4aee-9743-fa8cf19d3d75
15473350046ANDASun Pharma Global Fze2014-04-09OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATEANDA20292220910750-2bb6-4258-8368-df9ec207bfdd
16473350047ANDASun Pharma Global Fze2014-04-09OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATEANDA20292220910750-2bb6-4258-8368-df9ec207bfdd
17473350176ANDASun Pharma Global Fze2009-08-19OXALIPLATININTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA0788188efb4c07-455b-4c91-b257-6fd43854454c
18473350178ANDASun Pharma Global Fze2009-08-19OXALIPLATININTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA0788188efb4c07-455b-4c91-b257-6fd43854454c
19617030361ANDAHospira Worldwide, Inc.2009-09-30, 2011-09-08OXALIPLATININTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA07881580bb754d-38c2-483e-afae-b693f99896e8, d9400bde-4da8-49c8-a61e-15d2be58e73d
20617030362ANDAHospira Worldwide, Inc.2009-09-30, 2011-09-08OXALIPLATININTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA07881580bb754d-38c2-483e-afae-b693f99896e8, d9400bde-4da8-49c8-a61e-15d2be58e73d
21617030363ANDAHospira Worldwide, Inc.2009-08-07, 2009-08-25OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATEANDA078813d9400bde-4da8-49c8-a61e-15d2be58e73d, e51a62ba-d163-4c57-835c-8c86cf097e40
22633230175ANDAApp Pharmaceuticals, Llc2009-09-17OXALIPLATININTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA0788103f680321-398d-4941-a5d5-e3cdef549ee0
23633230176ANDAApp Pharmaceuticals, Llc2009-09-17OXALIPLATININTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONANDA0788103f680321-398d-4941-a5d5-e3cdef549ee0
24633230750ANDAApp Pharmaceuticals, Llc2010-06-11OXALIPLATININTRAVENOUSINJECTION, SOLUTION, CONCENTRATEANDA078811e12e2850-4980-48de-af58-15e559fb921f
25674570468ANDAMylan Institutional Llc2012-08-09OXALIPLATININTRAVENOUSPOWDER, FOR SOLUTIONANDA2009795023650b-d15b-4cce-a8cd-ccbdcd891f0c
26674570469ANDAMylan Institutional Llc2012-08-09OXALIPLATININTRAVENOUSINJECTION, SOLUTIONANDA091358da0e8523-609a-4326-96b1-d7de78662d91

application(s)

#idtitledeprecatedapplicantapprovedpatentapproved drug
1ANDA078803OXALIPLATINACTAVIS TOTOWA LLC2012-08-08ANDA078803_001, ANDA078803_002
2ANDA078810OXALIPLATINFRESENIUS KABI ONCOLOGY PLC2009-08-07ANDA078810_001, ANDA078810_002
3ANDA078811OXALIPLATINFRESENIUS KABI ONCOLOGY PLC2010-06-10ANDA078811_001, ANDA078811_002
4ANDA078812OXALIPLATINEBEWE PHARMA GES MBH NFG KG2009-08-07ANDA078812_001, ANDA078812_002
5ANDA078813OXALIPLATINHOSPIRA WORLDWIDE PTY2009-08-07ANDA078813_001, ANDA078813_002
6ANDA078815OXALIPLATINHOSPIRA INC2009-09-30ANDA078815_001, ANDA078815_002
7ANDA078817OXALIPLATINSANDOZ INC2011-01-24ANDA078817_001, ANDA078817_002
8ANDA078818OXALIPLATINSUN PHARMA GLOBAL FZE2009-08-07ANDA078818_001, ANDA078818_002
9ANDA078819OXALIPLATINFRESENIUS KABI USA LLC2010-06-02ANDA078819_001, ANDA078819_002
10ANDA090849OXALIPLATINTrueSANDOZ INC2011-04-28ANDA090849_001, ANDA090849_002
11ANDA091358OXALIPLATINMYLAN LABORATORIES LTD2012-08-07ANDA091358_001, ANDA091358_002
12ANDA200979OXALIPLATINMYLAN LABORATORIES LTD2012-08-08ANDA200979_001, ANDA200979_002
13ANDA202922OXALIPLATINSUN PHARMA GLOBAL FZE2014-04-08ANDA202922_001, ANDA202922_002
14ANDA203869OXALIPLATINJIANGSU HENGRUI MEDICINE CO LTD2014-06-18ANDA203869_001, ANDA203869_002
15NDA021492ELOXATINTrueSANOFI AVENTIS US LLC2002-08-09p5420319NDA021492_001, NDA021492_002
16NDA021759ELOXATINSANOFI AVENTIS US LLC2005-01-31p5420319
p5716988, SUBSTANCE
NDA021759_001, NDA021759_002, NDA021759_003
17NDA022160OXALIPLATINTEVA PHARMACEUTICALS USA2009-08-07NDA022160_001, NDA022160_002

application drug(s)

#idcategory/deprecatedingredient strength(s)dose formrldTEapprovedapplication
1ANDA078803_001RXOXALIPLATIN (50MG/VIAL)INJECTIONFalseAP2012-08-08OXALIPLATIN
2ANDA078803_002RXOXALIPLATIN (100MG/VIAL)INJECTIONFalseAP2012-08-08OXALIPLATIN
3ANDA078810_001RXOXALIPLATIN (50MG/VIAL)INJECTIONFalseAP2009-08-07OXALIPLATIN
4ANDA078810_002RXOXALIPLATIN (100MG/VIAL)INJECTIONFalseAP2009-08-07OXALIPLATIN
5ANDA078811_001RXOXALIPLATIN (50MG/10ML)INJECTIONFalseAP2010-06-10OXALIPLATIN
6ANDA078811_002RXOXALIPLATIN (100MG/20ML)INJECTIONFalseAP2010-06-10OXALIPLATIN
7ANDA078812_001RXOXALIPLATIN (50MG/10ML)INJECTIONFalseAP2009-08-07OXALIPLATIN
8ANDA078812_002RXOXALIPLATIN (100MG/20ML)INJECTIONFalseAP2009-08-07OXALIPLATIN
9ANDA078813_001RXOXALIPLATIN (50MG/10ML)INJECTIONFalseAP2009-08-07OXALIPLATIN
10ANDA078813_002RXOXALIPLATIN (100MG/20ML)INJECTIONFalseAP2009-08-07OXALIPLATIN
11ANDA078815_001RXOXALIPLATIN (50MG/VIAL)INJECTIONFalseAP2009-09-30OXALIPLATIN
12ANDA078815_002RXOXALIPLATIN (100MG/VIAL)INJECTIONFalseAP2009-09-30OXALIPLATIN
13ANDA078817_001RXOXALIPLATIN (50MG/10ML)INJECTIONFalseAP2011-01-24OXALIPLATIN
14ANDA078817_002RXOXALIPLATIN (100MG/20ML)INJECTIONFalseAP2011-01-24OXALIPLATIN
15ANDA078818_001RXOXALIPLATIN (50MG/VIAL)INJECTIONTrueAP2009-08-07OXALIPLATIN
16ANDA078818_002RXOXALIPLATIN (100MG/VIAL)INJECTIONTrueAP2009-08-07OXALIPLATIN
17ANDA078819_001RXOXALIPLATIN (50MG/VIAL)INJECTIONFalseAP2010-06-02OXALIPLATIN
18ANDA078819_002RXOXALIPLATIN (100MG/VIAL)INJECTIONFalseAP2010-06-02OXALIPLATIN
19ANDA090849_001discontinuedOXALIPLATIN (50MG/VIAL)INJECTIONFalse2011-04-28OXALIPLATIN
20ANDA090849_002discontinuedOXALIPLATIN (100MG/VIAL)INJECTIONFalse2011-04-28OXALIPLATIN
21ANDA091358_001RXOXALIPLATIN (50MG/10ML)INJECTIONFalseAP2012-08-07OXALIPLATIN
22ANDA091358_002RXOXALIPLATIN (100MG/20ML)INJECTIONFalseAP2012-08-07OXALIPLATIN
23ANDA200979_001RXOXALIPLATIN (50MG/VIAL)INJECTIONFalseAP2012-08-08OXALIPLATIN
24ANDA200979_002RXOXALIPLATIN (100MG/VIAL)INJECTIONFalseAP2012-08-08OXALIPLATIN
25ANDA202922_001RXOXALIPLATIN (50MG/10ML)INJECTIONFalseAP2014-04-08OXALIPLATIN
26ANDA202922_002RXOXALIPLATIN (100MG/20ML)INJECTIONFalseAP2014-04-08OXALIPLATIN
27ANDA203869_001RXOXALIPLATIN (50MG/10ML)INJECTIONFalseAP2014-06-18OXALIPLATIN
28ANDA203869_002RXOXALIPLATIN (100MG/20ML)INJECTIONFalseAP2014-06-18OXALIPLATIN
29NDA021492_001discontinuedOXALIPLATIN (50MG/VIAL)INJECTIONFalse2002-08-09ELOXATIN
30NDA021492_002discontinuedOXALIPLATIN (100MG/VIAL)INJECTIONFalse2002-08-09ELOXATIN
31NDA021759_001RXOXALIPLATIN (50MG/10ML)INJECTIONTrueAP2005-01-31ELOXATIN
32NDA021759_002RXOXALIPLATIN (100MG/20ML)INJECTIONTrueAP2005-01-31ELOXATIN
33NDA021759_003RXOXALIPLATIN (200MG/40ML)INJECTIONTrue2006-11-17ELOXATIN
34NDA022160_001RXOXALIPLATIN (50MG/10ML)INJECTIONTrueAP2009-08-07OXALIPLATIN
35NDA022160_002RXOXALIPLATIN (100MG/20ML)INJECTIONTrueAP2009-08-07OXALIPLATIN

patent(s)

#idexpiration dateapplication(s)
1p5420319 (view patent)2016-08-09NDA021492, NDA021759
2p5716988 (view patent)2015-08-07NDA021759

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
10fabb87d-72ff-4325-86dc-b53da680361e (view SPL)These highlights do not include all the information needed to use OXALIPLATIN injection safely and effectively. See full prescribing information for OXALIPLATIN injection. OXALIPLATIN injection for intravenous useInitial U.S. Approval: 2002prescriptionHuman PrescriptionApp Pharmaceuticals, Llc2014-08-071633230212, 633230211
220910750-2bb6-4258-8368-df9ec207bfdd (view SPL)These highlights do not include all the information needed to use OXALIPLATIN INJECTION safely and effectively. See full prescribing information for OXALIPLATIN INJECTION.OXALIPLATIN injection, for intravenous useInitial U.S. Approval: 2002prescriptionHuman PrescriptionSun Pharma Global FzeANALYSIS, MANUFACTURE2015-10-178473350046, 473350047
329a5d098-bfa7-4a65-bb4f-5daa1fef1c2f (view SPL)These highlights do not include all the information needed to use Oxaliplatin Injection, USP safely and effectively. See full prescribing information for Oxaliplatin Injection, USP.Oxaliplatin Injection, USP, for intravenous use. Initial U.S. Approval: 2002prescriptionHuman PrescriptionSagent Pharmaceuticals2014-07-222250210233
43c740b43-f396-4998-bc66-6964a21f7161 (view SPL)These highlights do not include all the information needed to use ELOXATIN safely and effectively. See full prescribing information for ELOXATIN. ELOXATIN (oxaliplatin) injection for intravenous use Initial U.S. Approval: 2002prescriptionHuman PrescriptionSanofi-Aventis U.S. LlcANALYSIS, LABEL, MANUFACTURE, PACK2015-10-0810000240591, 000240590
53f680321-398d-4941-a5d5-e3cdef549ee0 (view SPL)These highlights do not include all the information needed to use Oxaliplatin for Injection safely and effectively. See full prescribing information for Oxaliplatin for Injection. OXALIPLATIN FOR INJECTION powder, for solution for intravenous useInitial U.S. Approval: 2002prescriptionHuman Prescription with HighlightsApp Pharmaceuticals, LlcMANUFACTURE2009-07-315633230175, 633230176
65023650b-d15b-4cce-a8cd-ccbdcd891f0c (view SPL)These highlights do not include all the information needed to use Oxaliplatin for Injection, USP safely and effectively. See full prescribing information for Oxaliplatin for Injection, USP. OXALIPLATIN for Injection, USP for intravenous use.Initial U.S. Approval: 2002 Rx onlyprescriptionHuman PrescriptionMylan Institutional LlcAnalysis, Label, Manufacture, Pack, Sterilize2014-05-221674570468
76d020a9b-1244-45e5-b8d7-8342e85d7666 (view SPL)These highlights do not include all the information needed to use Oxaliplatin for Injection, USP safely and effectively. See full prescribing information for Oxaliplatin for Injection, USP.Oxaliplatin for Injection, USP, powder, for solution for intravenous use. Initial U.S. Approval: 2002prescriptionHuman PrescriptionSagent Pharmaceuticals2013-10-253250210211, 250210212
870269278-fe61-4800-a064-32cb6845cc28 (view SPL)These highlights do not include all the information needed to use oxaliplatin safely and effectively. See full prescribing information for oxaliplatin. Oxaliplatin injection for intravenous use Initial U.S. Approval: 2002prescriptionHuman PrescriptionWinthrop U.S.ANALYSIS, LABEL, MANUFACTURE, PACK2015-10-122009551731, 009551733
978f6a5f3-d088-4aee-9743-fa8cf19d3d75 (view SPL)These highlights do not include all the information needed to use Oxaliplatin for Injection, USP safely and effectively. See full prescribing information for Oxaliplatin for Injection, USP. OXALIPLATIN for injection, USP, powder, for solution for intravenous use. Initial U.S. Approval: 2002prescriptionHuman PrescriptionActavis Inc.ANALYSIS, LABEL, MANUFACTURE, PACK2014-06-2510459630611
1080bb754d-38c2-483e-afae-b693f99896e8 (view SPL)These highlights do not include all the information needed to use OXALIPLATIN safely and effectively. See full prescribing information for OXALIPLATIN. OXALIPLATIN for Injection, USP powder for solution for intravenous use Initial U.S. Approval: 2002prescriptionHuman PrescriptionHospira Worldwide, Inc.2015-05-1112617030361, 617030362
118efb4c07-455b-4c91-b257-6fd43854454c (view SPL)These highlights do not include all the information needed to use oxaliplatin for injection safely and effectively. See full prescribing information for oxaliplatin for injection. OXALIPLATIN for Injection, USP for intravenous use Initial U.S. Approval: 2002prescriptionHuman PrescriptionSun Pharma Global FzeANALYSIS, MANUFACTURE2015-05-065473350176, 473350178
1298e269f3-fd0f-4415-bf73-0cf6a1907204 (view SPL)prescriptionHuman PrescriptionAventis Pharma Ltd.MANUFACTURE2009-06-161125160592
139e51cc79-620c-48d7-b267-78e43c1ef6e4 (view SPL)These highlights do not include all the information needed to use OXALIPLATIN injection safely and effectively. See full prescribing information for OXALIPLATIN injection. OXALIPLATIN injection for intravenous useInitial U.S. Approval: 2002prescriptionHuman PrescriptionTeva Parenteral Medicines, Inc2014-07-156007033986, 007033985
14a83ff94d-956e-48de-bcb2-affff1c6f161 (view SPL)These highlights do not include all the information needed to use oxaliplatin for injection safely and effectively. See full prescribing information for oxaliplatin for injection. Oxaliplatin (oxaliplatin) powder, for solution for intravenous use Initial U.S. Approval: 2002prescriptionHuman Prescription with HighlightsSun Pharma Global Inc.2009-08-241416160176, 416160178
15a98b4070-822f-4fba-a844-690ff5556f0b (view SPL)These highlights do not include all the information needed to use oxaliplatin safely and effectively. See full prescribing information for oxaliplatin. Oxaliplatin injection for intravenous useInitial U.S. Approval: 2002prescriptionHuman PrescriptionWinthrop U.S.ANALYSIS, LABEL, MANUFACTURE, PACK2015-10-125009551725, 009551727
16ab162009-6f84-4d56-ab56-5e84409ec814 (view SPL)These highlights do not include all the information needed to use oxaliplatin injection safely and effectively. See full prescribing information for oxaliplatin injection. Oxaliplatin Injection, USP, Solution, Concentrate, for Intravenous Use Initial U.S. Approval: 2002prescriptionHuman PrescriptionSandoz Inc2015-10-205007813315, 007813317
17b114b6c1-8a19-480c-8459-c23cbdc3516a (view SPL)These highlights do not include all the information needed to use Oxaliplatin Injection USP safely and effectively. See full prescribing information for Oxaliplatin Injection USP.Oxaliplatin injection USP for intravenous useInitial U.S. Approval: 2002prescriptionHuman PrescriptionPfizer LabsAnalysis, Manufacture, Pack, Sterilize2012-07-031000690070
18d9400bde-4da8-49c8-a61e-15d2be58e73d (view SPL)These highlights do not include all the information needed to use Oxaliplatin Injection safely and effectively. See full prescribing information for Oxaliplatin Injection. Oxaliplatin for Injection, powder for solution for intravenous use Oxaliplatin Injection, solution for intravenous use Initial U.S. Approval: 2002prescriptionHuman PrescriptionHospira Worldwide, Inc.2011-11-282617030361, 617030362, 617030363
19da0e8523-609a-4326-96b1-d7de78662d91 (view SPL)These highlights do not include all the information needed to use Oxaliplatin Injection, USP safely and effectively. See full prescribing information for Oxaliplatin Injection, USP.OXALIPLATIN injection, USP for intravenous use.Initial U.S. Approval: 2002Rx onlyprescriptionHuman PrescriptionMylan Institutional LlcAnalysis, Label, Manufacture, Pack, Sterilize2014-03-281674570469
20e0890b0c-c1e9-4760-8914-0f28467d0e36 (view SPL)These highlights do not include all the information needed to use Oxaliplatin for Injection, USP safely and effectively. See full prescribing information for Oxaliplatin for Injection, USP. Oxaliplatin for Injection, USP for intravenous use.Initial U.S. Approval: 2002prescriptionHuman PrescriptionPfizer LabsAnalysis, Manufacture, Pack, Sterilize2013-02-142000690067
21e12e2850-4980-48de-af58-15e559fb921f (view SPL)These highlights do not include all the information needed to use Oxaliplatin Injection, USPsafely and effectively. See full prescribing information for Oxaliplatin Injection, USP.Oxaliplatin Injection, USPconcentrate, for solution for intavenous useInitial U.S. Approval: 2002prescriptionHuman PrescriptionApp Pharmaceuticals, LlcMANUFACTURE2015-05-2110633230750
22e51a62ba-d163-4c57-835c-8c86cf097e40 (view SPL)These highlights do not include all the information needed to use Oxaliplatin safely and effectively. See full prescribing information for Oxaliplatin.Oxaliplatin Injection, USP solution for intravenous useInitial U.S. Approval: 2002prescriptionHuman PrescriptionHospira Worldwide, Inc.2015-05-114617030363

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII